In both in vitro and in vivo models of pancreatic cancer, resveratrol induces gemcitabine chemosensitivity and suppresses sphere formation and markers of cancer stem cells by targeting SREBP-1, which indicates that resveratrol can be an effective sensitizer for chemotherapy (170). Here, SREBF1 is linked to cancer.